BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rah B, Banday MA, Bhat GR, Shah OJ, Jeelani H, Kawoosa F, Yousuf T, Afroze D. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World J Gastroenterol 2021; 27(36): 6093-6109 [PMID: 34629822 DOI: 10.3748/wjg.v27.i36.6093]
URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6093.htm
Number Citing Articles
Bilal Rah, Rafiq A Rather, Gh Rasool Bhat, Abdul Basit Baba, Ifra Mushtaq, Muzamil Farooq, Tahira Yousuf, Sadaf B Dar, Sabra Parveen, Rukhsana Hassan, Fozia Mohammad, Iqbal Qassim, Abida Bhat, Shazia Ali, Mahrukh Hamid Zargar, Dil Afroze. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid MalignanciesFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.821344
Maciej Wiewiora, Janusz Jopek, Elżbieta Świętochowska, Michael Grynkiewicz, Jerzy Piecuch. Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancerClinical Hemorheology and Microcirculation 2024; 86(3): 383 doi: 10.3233/CH-231987
Michelle F. Jacobs, Elena M. Stoffel. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)Familial Cancer 2024;  doi: 10.1007/s10689-024-00372-5
Lingxue Tang, Tong Wang, Qianqian Zhang, Sheng Yu, Wen Li, Senbang Yao, Huaidong Cheng, Yuan Seng Wu. Safety and Efficacy of Treatment with/without Ramucirumab in Advanced or Metastatic Cancer: A Meta-Analysis of 11 Global, Double-Blind, Phase 3 Randomized Controlled TrialsJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2476469
Cincin Zeynep Bulbul, Bulbul Muhammed Volkan, Sahin Soner. Cancer EpigeneticsEpigenetics and Human Health 2023; 11: 275 doi: 10.1007/978-3-031-42365-9_8
Abdul Basit Baba, Bilal Rah, Gh. Rasool Bhat, Ifra Mushtaq, Sabra Parveen, Rukhsana Hassan, Mahrukh Hameed Zargar, Dil Afroze. Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal WithinFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.791272